Friends of Cancer Research
To drive collaboration among partners from every healthcare sector to power advances in science, policy and regulation that speed life-saving treatments to patients.
Friends of Cancer Research at a glance
- Total assets
- $23,104,598
- +17.5% vs 2023
- Revenue (2024)
- $7,499,449
- +4.4% vs 2023
- Net investment income (2024)
- $549,939
- +86.0% vs 2023
- Expenses (2024)
- $5,771,194
- +10.0% vs 2023
- Latest 990 filing
- Form 990, 2024 View filing
Data from IRS Form 990, 2024; updated September 2026.
Who Friends of Cancer Research funds
How this funder distributes its grants
Grant Size Distribution
8 grants across all recorded years
The most common grant size was under $50K: 8 grants of 8 (100%).
Geographic Focus
Where this funder awards grants
Grant Distribution by State
Cities
Giving History
Giving Over Time
Total grant dollars and number of grants per year
From 2020 to 2021, annual grant giving ranged from $30K (2021) to $48K (2020). In 2021 it made 3 grants totaling $30K.
Grants by year
Grant recipients and amounts by year
| Recipient | Purpose | Amount |
|---|---|---|
| Fdn for Natl Inst of Health Bethesda, MD | Annual Contribution | $10,000 |
| Johns Hopkins University Baltimore, MD | Annual Contribution | $10,000 |
| Reagan Udall Foundation Gala Washington, DC | Annual Contribution | $10,000 |
Ready to take the next step with Friends of Cancer Research?
Financial History
Multi-year comparison from IRS filings
| Filing year | Total Assets | Revenue | Expenses | Grants paid | Grants | Net Investment Income |
|---|---|---|---|---|---|---|
| 2024 | $23,104,598 | $7,499,449 | $5,771,194 | — | — | $549,939 |
| 2023 | $19,663,708 | $7,186,730 | $5,245,007 | — | — | $295,644 |
| 2022 | $13,380,551 | $6,784,533 | $4,975,120 | — | — | $328,976 |
| 2021 | $13,600,990 | $5,525,309 | $3,563,423 | $30,000 | 3 | $502,337 |
| 2020 | $10,464,081 | $4,973,258 | $3,566,774 | $47,500 | 5 | $337,840 |
About Friends of Cancer Research
Based on IRS filings
Friends of Cancer Research is a public charity focused on Medical Research, based in Washington, DC. IRS filing data is available from 2020 through 2024. As of 2024, the organization holds $23.1M in total assets. Net investment income was $550K.
Focus Areas
Leadership & Key People
Officers and directors from IRS filings
Friends of Cancer Research is led by Jeff Allen PhD, President & CEO on every filing since 2020; 8 of 22 officers listed in 2024 are compensated.
Officers on the 2024 filing
Jeff Allen PhD
President & CEO
On filings since 2020
40 hrs/week
$546K (2020) → $645K (2024)
David Mitchell
Executive Director
Executive Committee → Executive Director, 2024
On filings since 2020
0.5 hrs/week
No compensation reported
Margaret Foti PhD MD
Executive Director
Executive Committee → Executive Director, 2024
On filings since 2020
0.5 hrs/week
No compensation reported
Richard Schilsky MD
Executive Director
Executive Committee → Executive Director, 2024
On filings since 2020
0.5 hrs/week
No compensation reported
Ellen V Sigal PhD
Chair & Founder
On filings since 2020
0.5 hrs/week
No compensation reported
Carolyn Bo Aldige
Director
On filings since 2020
0.5 hrs/week
No compensation reported
Edward J Benz Jr. MD
Director
On filings since 2020
0.5 hrs/week
No compensation reported
Elizabeth Thompson
Director
On filings since 2020
0.5 hrs/week
No compensation reported
Margaret Anderson
Director
On filings since 2020
0.5 hrs/week
No compensation reported
Pennie Abramson PhD
Director
On filings since 2020
0.5 hrs/week
No compensation reported
Edward Sanghyun Kim MD MBA
Director
On filings since 2023
0.5 hrs/week
No compensation reported
Roy Herbst MD PhD
Director
On filings since 2023
0.5 hrs/week
No compensation reported
Heather Chaney
Vp-Operations
On filings since 2020
40 hrs/week
$176K (2020) → $215K (2024)
Mark Stewart PhD
Vp-Science Policy
On filings since 2020
40 hrs/week
$161K (2020) → $286K (2024)
Ryan Hohman JD
Vp-Public Affairs
On filings since 2020
40 hrs/week
$240K (2020) → $300K (2024)
linda ostermann
Dir.-Grant & Oper
Grants Manager → Dir.-Grant & Oper, 2023
On filings since 2021
40 hrs/week
$102K (2021) → $154K (2024)
Brittany McKelvey
Dir.-Reg Affairs
On filings since 2023
40 hrs/week
$133K (2023) → $142K (2024)
Hillary Andrews
Dir.-Reg & Res Par
On filings since 2023
40 hrs/week
$162K (2023) → $179K (2024)
Finnian Galloway-Kane
Dir-Pub Relations
New on the 2024 filing
40 hrs/week
$113K (2024)
Anna D Barker PhD
Secretary
Secretary → Executive Committee, 2023
Executive Committee → Secretary, 2024
On filings since 2020
0.5 hrs/week
No compensation reported
Marlene A Malek RN
Vice Chair
On filings since 2020
0.5 hrs/week
No compensation reported
Sudip Parikh PhD
Treasurer
Treasurer → Executive Committee, 2023
Executive Committee → Treasurer, 2024
On filings since 2020
0.5 hrs/week
No compensation reported
Former officers (7)
- Former: Jonathan Leff (2020–2022) — Executive Committee
- Former: Robert C Young MD (2020–2022) — Director
- Former: Brittany Mcelvy (2022) — Director
- Former: Hillary Stires (2022) — Director
- Former: Diana Merino PhD (2020) — Director & Research Part
- Former: Laura Lasiter PhD (2020) — Director & Health Policy
- Former: Sherry Lansing (2020) — Director
Data from IRS Form 990 filings, 2020–2024. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.
Compensation Overview
From 2024 IRS filing
The highest reported compensation on the 2024 filing was $645K, to Jeff Allen PhD (President & CEO). 8 officers or directors reported compensation on that filing.
Frequently asked questions about Friends of Cancer Research
How large is Friends of Cancer Research?
Friends of Cancer Research reported $23.1M in total assets on its 2024 IRS Form 990. Its revenue that year was $7.5M.
What is Friends of Cancer Research?
Friends of Cancer Research is a public charity focused on Medical Research, based in Washington, DC. It holds $23.1M in total assets as of 2024.
Where does Friends of Cancer Research operate?
Friends of Cancer Research has awarded grants in District of Columbia, Maryland, Virginia.
What is Friends of Cancer Research's EIN?
Friends of Cancer Research's EIN (Employer Identification Number) is 52-1983273. IRS Form 990 filing data is available on this page for 2020–2024.
Data last updated September 2026. Sourced from IRS Form 990 filings.
Data update history
(3)
When this profile's IRS filing data changed on Grantable
- Updated Form 990 for fiscal year 2020 (received by the IRS June 25, 2021)
- Updated Form 990 for fiscal year 2021 (received by the IRS October 11, 2022)
- IRS filings on file for fiscal years 2020–2024
Live grants for the work Friends of Cancer Research funds
Medical Research Open opportunities, soonest deadline first.
- Annual Grants Up to $500,000 for translational/correlative grants; Up to $800,000 for clinical trials · Due November 15, 2026
- American Society of Pediatric Neurosurgeons Seed Grant Program $25,000 maximum for a 2-year award · Due November 15, 2026
- P.E.O. Scholar Awards (PSA) Up to $25,000 · Due November 20, 2026
Explore Open Grants
Browse active grant opportunities in Friends of Cancer Research's focus areas in our free grants database
Similar Funders
Funders with grantees in common
The Myositis Association
Columbia, MD
The mission of The Myositis Association, or TMA, is: to improve the lives of persons affected by myositis, fund innovative research, and increase myositis awareness and advocacy. TMA is the premier international organization providing important resources, education and support to those in the myositis community. This community consists of children, adults, and their families who live with the daunting and life-changing physical, psychological and emotional effects of myositis. Nationwide, an estimated 75,000 Americans are affected by this collection of rare diseases. Symptoms of myositis include, but are not limited to: muscle weakness pain fatigue tripping or falling trouble swallowing difficulty breathing and irritations of the skin, joints, and eyes. Myositis is often difficult to diagnose, because many physicians are unfamiliar with the disease and its symptoms. Also, as a rare disease, it can be difficult to enroll enough patients to conduct adequate research of new treatments, an
Assets
$2.0M
Grants
3
Total Given
$81K
Curepsp Inc
New York, NY
CurePSP funds research on PSP, CBD, and MSA, as well as patient and caregiver services, education, and care programs. Its 2025 grants ranged from $6,000 to $200,000, with a median of $77,237, and supported recipients in multiple states. It has invited research proposals from academic and non-academic institutions, but the published application deadline was in 2023; no current cycle is established.
Assets
$11.0M
Grants
16
Total Given
$1.2M
Critical Path Institute
Tucson, AZ
Critical Path Institute supports collaborative research and drug-development efforts, including rare and other diseases, and offers awards for academic researchers developing small-molecule therapeutics. Its 2025 grants ranged from $23,000 to $1,319,385, with a median of $127,093; its TRxA program offers up to $250,000, $500,000, or $1 million, and accepts applications from eligible university and nonprofit faculty worldwide.
Assets
$38.4M
Grants
17
Total Given
$3.8M
The Foundation for AIDS Research
New York, NY
amfAR funds research, policy advocacy, and global health work focused primarily on HIV/AIDS, including HIV care and prevention in the Asia-Pacific region. In 2025, its 18 grants ranged from $10,204 to $410,149, with a median of $50,000, supporting organizations in multiple U.S. states and the Asia-Pacific; research grants are made through formal requests for proposals and peer review, not general unsolicited requests.
Assets
$58.0M
Grants
18
Total Given
$2.5M
American Academy of Sleep Medicine Foundation
Darien, IL
The Foundation funds sleep-health research, investigator career development and training, community programs, and disaster relief for sleep centers. Its 2024 grants ranged from about $10,000 to $540,000, with a median of $100,000; no geographic focus is stated. It accepts letters of intent for its Strategic Research Grant, with full applications by invitation.
Assets
$18.2M
Grants
23
Total Given
$3.7M
The Cyrus Katzen Foundation Inc
Baileys Crossroads, VA
The Cyrus Katzen Foundation funds health care and medical research, children’s services, arts and culture, and community and religious organizations. Its 2025 grants ranged from $2,000 to $812,500, with a median of $10,000, and went mainly to organizations in Washington, DC, and Maryland. It accepts requests: applicants should submit a letter describing the organization and grant purpose, along with proof of tax-exempt status; no deadline is listed.
Assets
$35.7M
Grants
35
Total Given
$1.7M
More similar funders
More Funders in District of Columbia
The filing figures on this page are open data under CC BY 4.0. About GrantGraph Open
Figures come from Friends of Cancer Research's IRS filings (methodology). AI-written summaries, news items and logos are not covered by the open licence. Spot an error? Email hello@grantable.co.
Friends of Cancer Research down — hundreds of funders to go?